sympazan Drug Patent Profile
✉ Email this page to a colleague
When do Sympazan patents expire, and when can generic versions of Sympazan launch?
Sympazan is a drug marketed by Otter Pharms and is included in one NDA. There are three patents protecting this drug.
This drug has one hundred and sixty-eight patent family members in nineteen countries.
The generic ingredient in SYMPAZAN is clobazam. There are ten drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the clobazam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sympazan
A generic version of sympazan was approved as clobazam by AMNEAL on October 22nd, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for sympazan?
- What are the global sales for sympazan?
- What is Average Wholesale Price for sympazan?
Summary for sympazan
International Patents: | 168 |
US Patents: | 3 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 37 |
Patent Applications: | 3,805 |
Drug Prices: | Drug price information for sympazan |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for sympazan |
What excipients (inactive ingredients) are in sympazan? | sympazan excipients list |
DailyMed Link: | sympazan at DailyMed |
Pharmacology for sympazan
Drug Class | Benzodiazepine |
Mechanism of Action | Cytochrome P450 2D6 Inhibitors Cytochrome P450 3A4 Inducers |
US Patents and Regulatory Information for sympazan
sympazan is protected by three US patents.
Patents protecting sympazan
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF TREATING SEIZURES
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-001 | Nov 1, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-003 | Nov 1, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-002 | Nov 1, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-003 | Nov 1, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-001 | Nov 1, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-001 | Nov 1, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-002 | Nov 1, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for sympazan
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-001 | Nov 1, 2018 | ⤷ Sign Up | ⤷ Sign Up |
Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-003 | Nov 1, 2018 | ⤷ Sign Up | ⤷ Sign Up |
Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-002 | Nov 1, 2018 | ⤷ Sign Up | ⤷ Sign Up |
Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-001 | Nov 1, 2018 | ⤷ Sign Up | ⤷ Sign Up |
Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-003 | Nov 1, 2018 | ⤷ Sign Up | ⤷ Sign Up |
Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-002 | Nov 1, 2018 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for sympazan
See the table below for patents covering sympazan around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 2120897 | FILMS À BASE DE POLYMÈRES ET SYSTÈMES DE DÉLIVRANCE DE MÉDICAMENTS FABRIQUÉS À PARTIR DE CEUX-CI (POLYMER-BASED FILMS AND DRUG DELIVERY SYSTEMS MADE THEREFROM) | ⤷ Sign Up |
Australia | 2002332118 | ⤷ Sign Up | |
Japan | 5165888 | ⤷ Sign Up | |
Canada | 2630261 | COMPOSITIONS DE FILMS TOPIQUES POUR LA LIBERATION D'ACTIFS (TOPICAL FILM COMPOSITIONS FOR DELIVERY OF ACTIVES) | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2007075422 | ⤷ Sign Up | |
Japan | 6448096 | ⤷ Sign Up | |
Australia | 2005292271 | Multi-layer films having uniform content | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |